Oxaliplatin Accord 5 mg/ml

DRUG3 trials

Sponsors

Goethe University Frankfurt, Turku University Hospital, HUS-Yhtymae

Conditions

CancerRectal cancerintermediate and high-risk rectal cancer

Phase 3

Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined intermediate and high-risk rectal cancer patients, A randomized phase III trial of the German Rectal Cancer Study Group

Active, not recruitingCTIS2024-511577-29-01

Goethe University Frankfurtintermediate and high-risk rectal cancer

Start: 2020-03-13Target: 688Updated: 2026-01-26

Phase 4

The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Quality of Life

RecruitingCTIS2024-513437-21-00

Turku University HospitalCancer

Start: 2024-10-02Target: 250Updated: 2024-07-26

Systemic Neoadjuvant and adjuvant Control by Precision medicine in rectal cancer (SYNCOPE) – approach on high-risk group to reduce metastases

Not yet recruitingCTIS2024-517149-15-00

HUS-YhtymaeRectal cancer

Target: 100Updated: 2024-09-24